AMD is a progressive disease of the retina, the part of the eye that detects visual signals and sends them to the brain. It is the leading cause of vision loss in people over 65, and there is no cure. There are two forms of AMD:
• The dry form accounts for 85 to 90% of AMD cases
• The wet form accounts for 10 to 15% of AMD cases

Your symptoms may be mild, or you may have no symptoms for several years. If your dry AMD progresses, your ability to see clearly may decline. Dry AMD can cause retinal cells to deteriorate and may result in cellular death, leading to geographic atrophy and permanent vision loss.
You may experience:
• Blurry or fuzzy vision
• Straight lines appear wavy or bent
• Reduced intensity/brightness of colors
• Trouble adapting to low light
• Loss of central vision, which is necessary for driving, reading, recognizing faces and performing close-up work

Healthy retinal cells are important for good vision. While there is no cure for dry AMD, early treatment is important.

Valeda is the first and only treatment for dry AMD. Valeda uses photobiomodulation (PBM), specific wavelengths of light, to stimulate energy production within the cells resulting in improved cellular health.

Treatment with Valeda can improve your vision now and in the future.

Treatment with Valeda can help you see more clearly now and in the future. Retinal imaging indicates improvement in eye scans when assessed for drusen (protein deposits observed in eyes with dry AMD).

84% of Valeda™ PBM–treated patients maintained or improved vision at about 2 years compared to baseline.1,2†

More than 60% of Valeda™ PBM–treated patients experienced ≥1-line vision improvement at about 2 years compared to baseline. 1,2†

1. Valeda US LIGHTSITE III Exhibit Data. [REF-28187]
2. Valeda US User Manual 2025

Valeda uses photobiomodulation (PBM), specific wavelengths of low-level light therapy, to stimulate energy production within the eye, resulting in improved cellular health. Healthy retinal cells are essential for maintaining good vision. 

No special preparation is needed before treatment. You will need to remove glasses or contact lenses. There are no eye drops, drugs, or needles used in the treatment. There is no discomfort during or after the treatment. The active treatment time is less than 5 minutes per eye per session.

You will receive 9 treatments over 3 to 5 weeks during each series. Typically, a series is repeated every 4 months. Your doctor will determine your plan.

Due to the exposure to bright lights, you may experience an afterimage following treatment. This is known as photostress. Normal photostress recovery time is approximately 15-30 seconds. Following treatment, you will be able to resume normal activities.

There have been no treatment-related side effects in clinical trials with Valeda. Consult your eye doctor for an explanation of the benefits and risks associated with Valeda treatment. Valeda is authorized by the U.S. Food & Drug Administration (FDA) and is available by prescription only.